Mark K. Ferguson to Radiopharmaceuticals
This is a "connection" page, showing publications Mark K. Ferguson has written about Radiopharmaceuticals.
Connection Strength
0.082
-
Developing a clinical and PET/CT volumetric prognostic index for risk assessment and management of NSCLC patients after initial therapy. Front Biosci (Landmark Ed). 2022 01 12; 27(1):16.
Score: 0.048
-
Prognostic value of quantitative PET/CT in patients with a nonsmall cell lung cancer and another primary cancer. Nucl Med Commun. 2017 Feb; 38(2):185-192.
Score: 0.034